Viridian Therapeutics (VRDN) has an average rating of buy and mean price target of $32.87, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Price: $18.47, Change: $+0.57, Percent Change: +3.18%